Two prominent organizations have awarded a total of $7.75 million in grants to fund cancer treatment research at the Knight Cancer Institute at Oregon Health & Science University.
The Leukemia & Lymphoma Society has awarded $6.25 million in grants to the Knight Cancer Institute to finance research into treatments for hematologic cancers including leukemia, lymphoma and myeloma. The research will be led by the institute's famed director, Dr. Brian Druker, widely credited for his development of the drug Gleevec, which has transformed the lives of patients with chronic myeloid leukemia (CML).
An additional $1.5 million across three grants has been awarded by the Susan G. Komen for the Cure to fund research into treatments for breast cancer, including improved screening and investigations into the genetic origins of the disease.
By Ross Bonander
SOURCE(S)
BizJournals
The information provided on CancerTreatment.net is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of CancerTreatment.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
